7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 
      
    		                               
      assets
    		                               
      current assets:
    		                               
      cash and cash equivalents
    		238,000,000 248,000,000 192,000,000 150,000,000 201,000,000 156,000,000 185,000,000 127,000,000 184,000,000 230,000,000 238,000,000 206,000,000 217,647,000 272,629,000 548,783,000 147,914,000 179,432,000 320,482,000 390,260,000 173,415,000 221,849,000 285,185,000 67,326,000 57,937,000 78,992,000 76,068,000 68,499,000 71,064,000 74,889,000 169,998,000 198,116,000 
      marketable securities
    		593,000,000 663,000,000 805,000,000 828,000,000 888,000,000 813,000,000 810,000,000 632,000,000 615,000,000 700,000,000 716,000,000 803,000,000                    
      receivable from collaboration partners
    		11,000,000 15,000,000 15,000,000 20,000,000 16,000,000 28,000,000 35,000,000 38,000,000 52,000,000 34,000,000 33,000,000 39,000,000 27,286,000 35,831,000 29,419,000 744,595,000 871,000 1,575,000 5,235,000 1,049,000 2,579,000 222,000 344,000  5,276,000       
      prepaid expenses and other current assets
    		15,000,000 20,000,000 19,000,000 18,000,000 22,000,000 25,000,000 34,000,000 34,000,000 31,000,000 22,000,000 28,000,000  21,625,000 15,672,000 18,527,000 15,620,000 17,574,000 21,967,000 8,680,000 5,471,000 11,816,000 8,665,000 8,007,000 4,303,000 4,223,000 3,273,000 3,080,000 2,321,000 2,329,000 1,550,000 1,834,000 
      total current assets
    		857,000,000 946,000,000 1,031,000,000 1,016,000,000 1,127,000,000 1,022,000,000 1,064,000,000 831,000,000 882,000,000 986,000,000 1,015,000,000 1,067,000,000 1,101,116,000 1,227,475,000 1,264,226,000 1,261,750,000 545,288,000 745,954,000 841,870,000 735,815,000 797,199,000 471,599,000 166,217,000 192,705,000 200,488,000 227,733,000 245,015,000 258,948,000 265,280,000 267,441,000 282,068,000 
      long-term marketable securities
    		10,000,000 16,000,000 8,000,000 14,000,000 2,000,000 40,000,000 100,000,000 107,000,000 151,000,000 80,000,000 90,000,000 129,000,000                    
      property and equipment
    		42,000,000 44,000,000 46,000,000 47,000,000 48,000,000 49,000,000 51,000,000 51,000,000 50,000,000 45,000,000 37,000,000 35,000,000 33,892,000 33,416,000 33,481,000 32,455,000 28,818,000 23,806,000 14,849,000 10,807,000 8,728,000 8,264,000 8,761,000 9,330,000 10,011,000 10,362,000 11,026,000 11,107,000 11,762,000   
      other noncurrent assets
    		65,000,000 69,000,000 71,000,000 73,000,000 75,000,000 75,000,000 78,000,000 106,000,000 108,000,000 109,000,000 112,000,000 114,000,000                    
      total assets
    		974,000,000 1,075,000,000 1,156,000,000 1,150,000,000 1,252,000,000 1,186,000,000 1,293,000,000 1,095,000,000 1,191,000,000 1,220,000,000 1,254,000,000 1,345,000,000 1,393,822,000 1,476,773,000 1,543,427,000 1,591,898,000 839,290,000 898,773,000 935,119,000 772,292,000 811,075,000 481,389,000 176,144,000 203,110,000 216,957,000 238,974,000 258,530,000 274,925,000 286,721,000 293,865,000 305,399,000 
      liabilities and stockholders' equity
    		                               
      current liabilities:
    		                               
      accounts payable
    		42,000,000 29,000,000 22,000,000 18,000,000 13,000,000 15,000,000 16,000,000 17,000,000 17,000,000 12,000,000 28,000,000 20,000,000 10,546,000 21,984,000 18,094,000 10,261,000 13,219,000 16,957,000 24,544,000 15,682,000 8,102,000 12,052,000 2,426,000 4,704,000 2,905,000 2,448,000 2,829,000 3,102,000 2,109,000 5,388,000 3,920,000 
      deferred revenue
    		52,000,000 71,000,000 72,000,000 85,000,000 105,000,000 113,000,000 124,000,000 91,000,000 103,000,000 103,000,000 97,000,000 97,000,000                    
      other current liabilities
    		141,000,000 110,000,000 98,000,000 123,000,000 97,000,000 71,000,000 64,000,000 76,000,000 80,000,000 65,000,000 54,000,000 76,000,000 2,984,000 2,466,000  52,000 209,000 380,000 2,381,000 3,566,000 3,422,000 1,463,000 1,408,000 1,480,000 1,490,000 1,513,000 1,545,000 1,560,000 1,585,000 1,650,000 1,732,000 
      total current liabilities
    		235,000,000 210,000,000 192,000,000 226,000,000 215,000,000 199,000,000 204,000,000 184,000,000 200,000,000 180,000,000 179,000,000 193,000,000 177,176,000 164,024,000 161,254,000 166,084,000 142,866,000 130,370,000 132,055,000 121,669,000 162,871,000 40,025,000 21,004,000 22,706,000 21,057,000 26,513,000 19,003,000 16,935,000 16,611,000 16,380,000 14,262,000 
      deferred revenue, noncurrent
    		53,000,000 60,000,000 219,000,000 234,000,000 289,000,000 214,000,000 242,000,000 307,000,000 326,000,000 330,000,000 330,000,000 355,000,000 382,584,000 429,339,000 456,905,000 462,217,000 94,675,000 103,908,000 113,369,000 122,830,000 91,298,000 8,522,000 10,272,000 12,022,000 13,772,000 10,522,000 12,272,000 16,984,000 18,546,000 16,087,000 17,337,000 
      long-term debt
    		98,000,000 97,000,000 48,000,000 48,000,000 47,000,000                           
      other noncurrent liabilities
    		152,000,000 159,000,000 166,000,000 157,000,000 136,000,000 138,000,000 140,000,000 142,000,000 145,000,000 144,000,000 145,000,000 140,000,000                    
      commitments
    		                               
      stockholders’ equity:
    		                               
      common shares, ...
    		1,815,000,000 1,793,000,000 1,775,000,000 1,617,000,000 1,602,000,000 1,582,000,000 1,561,000,000 1,311,000,000 1,291,000,000 1,267,000,000 1,226,000,000 1,206,000,000                    
      accumulated deficit
    		-1,379,000,000 -1,244,000,000 -1,244,000,000 -1,132,000,000 -1,038,000,000 -946,000,000 -853,000,000 -849,000,000 -768,000,000 -697,000,000 -622,000,000 -542,000,000 -474,898,000 -409,979,000 -343,347,000 -275,354,000 -554,722,000 -476,747,000 -400,777,000 -328,184,000 -276,331,000 -278,153,000 -233,079,000 -205,326,000 -188,728,000 -166,376,000 -138,286,000 -122,828,000 -110,533,000 -99,722,000 -86,188,000 
      total stockholders’ equity
    		436,000,000 549,000,000 531,000,000 485,000,000 565,000,000 635,000,000 707,000,000 462,000,000 520,000,000 566,000,000 600,000,000 657,000,000 698,701,000 747,386,000 796,579,000 841,450,000 542,607,000 604,555,000 664,790,000 502,304,000 544,417,000 428,710,000 140,638,000 163,842,000 177,227,000 196,646,000 221,567,000 234,942,000 245,121,000 254,574,000 266,591,000 
      total liabilities and stockholders’ equity
    		974,000,000 1,075,000,000 1,156,000,000 1,150,000,000 1,252,000,000 1,186,000,000 1,293,000,000 1,095,000,000 1,191,000,000 1,220,000,000 1,254,000,000 1,345,000,000 1,393,822,000 1,476,773,000 1,543,427,000 1,591,898,000 839,290,000 898,773,000 935,119,000 772,292,000 811,075,000 481,389,000  203,110,000        
      accumulated other comprehensive loss
    		    1,000,000 -1,000,000 -1,000,000  -3,000,000 -4,000,000 -4,000,000 -7,000,000 -9,801,000 -7,244,000 -4,660,000             -107,000 -108,000 -83,000 -97,000 
      preferred stock, 0.0001 par value per share; 10.0 shares authorized; no shares issued and outstanding.
    		                               
      prepaid and other current assets
    		           19,000,000                    
      preferred stock: 0.0001 par value per share; 10.0 shares authorized; no shares issued and outstanding
    		                               
      short-term investments
    		            831,135,000 900,147,000 664,751,000 351,394,000 345,210,000 400,530,000 436,666,000 555,231,000 560,583,000 177,288,000 90,540,000 130,333,000 111,997,000 148,330,000 173,436,000 185,480,000 182,948,000 95,700,000 82,064,000 
      accrued interest receivable
    		            3,423,000 3,196,000 2,746,000 2,227,000 2,201,000 1,400,000 1,029,000 649,000 372,000 239,000          
      long-term investments
    		            143,138,000 98,329,000 128,836,000 181,990,000 218,730,000 84,096,000 57,986,000 6,440,000 2,700,000    5,992,000  1,201,000 3,181,000 7,746,000 11,792,000 10,595,000 
      right-of-use assets
    		            102,073,000 104,025,000 102,992,000 104,968,000 35,553,000 36,137,000 12,243,000 12,781,000            
      restricted cash
    		            3,005,000 3,005,000 3,005,000 3,005,000 3,005,000 3,005,000 1,988,000 203,000 203,000 203,000 203,000 203,000 203,000 203,000 203,000 203,000 203,000 203,000 203,000 
      other long-term assets
    		            10,598,000 10,523,000 10,887,000 7,730,000 7,896,000 5,775,000 6,183,000 6,246,000 2,245,000 1,323,000 963,000 872,000 263,000 319,000 315,000 284,000 205,000 205,000 205,000 
      accrued research and development
    		            39,827,000 35,019,000 37,654,000 29,587,000 40,470,000               
      other accrued liabilities
    		            20,528,000 14,438,000 16,196,000 24,181,000 14,625,000 9,706,000 7,536,000 9,543,000 7,496,000 5,611,000          
      deferred revenue, current
    		            103,291,000 90,117,000 89,310,000 102,003,000 74,343,000 74,571,000 74,571,000 74,571,000 115,614,000 7,000,000 7,000,000 7,000,000 7,000,000 7,000,000 7,000,000 6,250,000 6,250,000 5,000,000 5,000,000 
      operating lease liabilities, noncurrent
    		            119,195,000 121,343,000 114,815,000 116,887,000 48,943,000 49,741,000 14,706,000 15,243,000            
      other long-term liabilities
    		            16,166,000 14,681,000 13,874,000 5,260,000 10,199,000 10,199,000 10,199,000 10,246,000 8,178,000 693,000 640,000 806,000 1,026,000 1,283,000 1,543,000 1,792,000 2,047,000 2,308,000 2,554,000 
      total liabilities
    		            695,121,000 729,387,000 746,848,000 750,448,000 296,683,000 294,218,000 270,329,000 269,988,000 266,658,000 52,679,000 35,506,000 39,268,000 39,730,000 42,328,000 36,963,000 39,983,000 41,600,000 39,291,000 38,808,000 
      preferred stock, 0.0001 par value, 10,000,000 shares authorized; no shares issued and outstanding.
    		                               
      common stock
    		            7,000 7,000 7,000 7,000 7,000 7,000 7,000 6,000 6,000 6,000 4,000 4,000 4,000 4,000 4,000 4,000 4,000   
      additional paid-in capital
    		            1,183,393,000 1,164,602,000 1,144,579,000 1,118,058,000 1,097,414,000 1,081,341,000 1,065,562,000 830,438,000 820,661,000 706,713,000 373,425,000 369,100,000 365,898,000 362,905,000 359,820,000 357,873,000 355,758,000 354,375,000 352,872,000 
      preferred stock, 0.0001 par value, 10,000,000 shares authorized as of june 30, 2022 and december 31, 2021; no shares issued and outstanding as of june 30, 2022 and december 31, 2021
    		                               
      preferred stock, 0.0001 par value, 10,000,000 shares authorized as of march 31, 2022 and december 31, 2021; no shares issued and outstanding as of march 31, 2022 and december 31, 2021
    		                               
      liabilities
    		                               
      preferred stock, 0.0001 par value, 10,000,000 shares authorized as of december 31, 2021 and 2020; no shares issued and outstanding as of december 31, 2021 and 2020
    		                               
      accumulated other comprehensive income
    		               -1,261,000 -92,000 -46,000 -2,000 44,000 81,000 144,000 288,000 64,000 53,000 113,000 29,000     
      preferred stock, 0.0001 par value, 10,000,000 shares authorized as of september 30, 2021 and december 31, 2020; no shares issued and outstanding as of september 30, 2021 and december 31, 2020
    		                               
      accrued research and development expenses
    		                 28,756,000 23,023,000 18,307,000 28,237,000 13,899,000          
      preferred stock, 0.0001 par value, 10,000,000 shares authorized as of june 30, 2021 and december 31, 2020; no shares issued and outstanding as of june 30, 2021 and december 31, 2020
    		                               
      preferred stock, 0.0001 par value, 10,000,000 shares authorized as of march 31, 2021 and december 31, 2020; no shares issued and outstanding as of march 31, 2021 and december 31, 2020
    		                               
      deferred rent, non-current
    		                               
      preferred stock, 0.0001 par value, 10,000,000 shares authorized as of december 31, 2020 and 2019; no shares issued and outstanding as of december 31, 2020 and 2019
    		                               
      current liabilities
    		                               
      deferred rent, noncurrent
    		                    4,311,000           
      preferred stock, 0.0001 par value, 10,000,000 shares authorized as of september 30, 2020 and december 31, 2019; no shares issued and outstanding as of september 30, 2020 and december 31, 2019
    		                               
      deferred rent
    		                     3,439,000 3,590,000 3,734,000 3,875,000 4,010,000 4,145,000 4,272,000 4,396,000 4,516,000 4,655,000 
      preferred stock, 0.0001 par value, 10,000,000 shares authorized as of june 30, 2020 and december 31, 2019; no shares issued and outstanding as of june 30, 2020 and december 31, 2019
    		                               
      accrued liabilities
    		                      10,170,000 9,522,000 9,662,000 15,552,000 7,629,000 6,023,000 6,667,000 4,342,000 3,610,000 
      preferred stock, 0.0001 par value, 10,000,000 shares authorized as of march 31, 2020 and december 31, 2019; no shares issued and outstanding as of march 31, 2020 and december 31, 2019
    		                               
      total liabilities, convertible preferred stock and stockholders’ equity
    		                      176,144,000  216,957,000 238,974,000 258,530,000 274,925,000 286,721,000 293,865,000 305,399,000 
      receivable from collaboration partner
    		                       132,000     5,000,000   
      amounts owed by a related party
    		                         62,000  83,000 114,000 193,000 54,000 
      equity investment in related party
    		                         357,000 770,000 1,202,000 1,525,000 1,711,000 515,000 
      preferred stock, 0.0001 par value, 10,000,000 shares authorized as of december 31, 2019 and 2018; no shares issued and outstanding as of december 31, 2019 and 2018
    		                               
      preferred stock, 0.0001 par value, 10,000,000 shares authorized as of september 30, 2019 and december 31, 2018; no shares issued and outstanding as of september 30, 2019 and december 31, 2018
    		                               
      preferred stock, 0.0001 par value, 10,000,000 shares authorized as of june 30, 2019 and december 31, 2018; no shares issued and outstanding as of june 30, 2019 and december 31, 2018
    		                               
      preferred stock, 0.0001 par value, 10,000,000 shares authorized as of march 31, 2019 and december 31, 2018; no shares issued and outstanding as of march 31, 2019 and december 31, 2018
    		                               
      convertible preferred stock
    		                               
      stockholders’ equity
    		                               
      preferred stock, 0.0001 par value, 10,000,000 shares authorized as of december 31, 2018; no shares issued and outstanding
    		                               
      preferred stock, 0.0001 par value, 10,000,000 shares and no shares authorized as of september 30, 2018 and december 31, 2017, respectively; no shares issued and outstanding as of september 30, 2018 and december 31, 2017, respectively
    		                               
      property, plant and equipment-net
    		                             12,513,000 11,813,000 
      preferred stock, 0.0001 par value, 10,000,000 shares and no shares authorized as of june 30, 2018 and december 31, 2017, respectively; no shares issued and outstanding as of june 30, 2018 and december 31, 2017, respectively
    		                               
      common stock; 0.0001 par value; 400,000,000 and 153,993,227 shares authorized as of june 30, 2018 and december 31, 2017, respectively; 44,456,659 and 4,090,898 shares issued and outstanding as of june 30, 2018 and december 31, 2017 respectively
    		                             4,000  
      preferred stock, 0.0001 par value, 10,000,000 shares and no shares authorized as of march 31, 2018 and december 31, 2017, respectively; no shares issued and outstanding as of march 31, 2018 and december 31, 2017, respectively
    		                               
      common stock; 0.0001 par value; 400,000,000 and 153,993,227 shares authorized as of march 31, 2018 and december 31, 2017, respectively; 44,454,275 and 4,090,898 shares issued and outstanding as of march 31, 2018 and december 31, 2017 respectively
    		                              4,000 
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.